Genomic Instability and Tumorigenesis are Long-Term Effects of Therapeutic CRISPR/Cas9 Genome Editing in Hereditary Tyrosinemia Type I

被引：0

作者：

Bissig, Karl-Dimiter ^{[1
]}

Furey, Nika ^{[1
]}

Chen, Tong ^{[1
]}

Kim, Hyunjae Ryan ^{[2
]}

Pankowicz, Francis ^{[2
]}

Barzi, Mercedes ^{[1
]}

Legras, Xavier ^{[1
]}

Martins, Celeste Santos ^{[2
]}

Elsea, Sarah ^{[3
]}

Hurley, Ayrea ^{[2
]}

Wheeler, David ^{[2
]}

Borowiak, Malgorzata ^{[2
]}

Bissig-Choisat, Beatrice ^{[1
]}

Lagor, William ^{[2
]}

Sumazin, Pavel ^{[2
]}

机构：

[1] Duke Univ, Durham, NC USA

[2] Baylor Coll Med, Houston, TX 77030 USA

[3] Baylor Coll Med, Houston, NC USA

来源：

MOLECULAR THERAPY | 2020年 / 28卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

961

引用

页码：419 / 420

页数：2

共 50 条

[21] LONG-TERM EFFECTS OF IN VIVO GENOME EDITING IN THE MOUSE RETINA USING CAMPYLOBACTER JEJUNI CAS9
Kim, J.
CYTOTHERAPY, 2023, 25 (06) : S264 - S264
[22] In vivo therapeutic genome editing via CRISPR/Cas9 magnetoplexes for myocardial infarction
Park, Hanseul
Kim, Dongyoon
Cho, Byounggook
Byun, Junho
Kim, Yong Sook
Ahn, Youngkeun
Hur, Jin
Oh, Yu-Kyoung
Kim, Jongpil
BIOMATERIALS, 2022, 281
[23] New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer
Ahmed, Munazza
Daoud, Grace Hope
Mohamed, Asmaa
Harati, Rania
GENES, 2021, 12 (05)
[24] Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
Francis P. Pankowicz
Mercedes Barzi
Xavier Legras
Leroy Hubert
Tian Mi
Julie A. Tomolonis
Milan Ravishankar
Qin Sun
Diane Yang
Malgorzata Borowiak
Pavel Sumazin
Sarah H. Elsea
Beatrice Bissig-Choisat
Karl-Dimiter Bissig
Nature Communications, 7
[25] Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
Pankowicz, Francis P.
Barzi, Mercedes
Legras, Xavier
Hubert, Leroy
Mi, Tian
Tomolonis, Julie A.
Ravishankar, Milan
Sun, Qin
Yang, Diane
Borowiak, Malgorzata
Sumazin, Pavel
Elsea, Sarah H.
Bissig-Choisat, Beatrice
Bissig, Karl-Dimiter
NATURE COMMUNICATIONS, 2016, 7
[26] Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALS
Deng, Han-Xiang
Zhai, Hong
Shi, Yong
Liu, Guoxiang
Lowry, Jessica
Liu, Bin
Ryan, Eanna B.
Yan, Jianhua
Yang, Yi
Zhang, Nigel
Yang, Zhihua
Liu, Erdong
Ma, Yongchao C.
Siddique, Teepu
COMMUNICATIONS BIOLOGY, 2021, 4 (01)
[27] Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALS
Han-Xiang Deng
Hong Zhai
Yong Shi
Guoxiang Liu
Jessica Lowry
Bin Liu
Éanna B. Ryan
Jianhua Yan
Yi Yang
Nigel Zhang
Zhihua Yang
Erdong Liu
Yongchao C. Ma
Teepu Siddique
Communications Biology, 4
[28] In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
Schuh, Roselena Silvestri
Poletto, Edina
Pasqualim, Gabriela
Vicente Tavares, Angela Maria
Meyer, Fabiola Shons
Gonzalez, Esteban Alberto
Giugliani, Roberto
Matte, Ursula
Teixeira, Helder Ferreira
Baldo, Guilherme
JOURNAL OF CONTROLLED RELEASE, 2018, 288 : 23 - 33
[29] Long-Term Multicolor Tracking of Genomic Loci by Modified sgRNAs of the CRISPR/Cas9 System
Shao, Shipeng
BIOPHYSICAL JOURNAL, 2016, 110 (03) : 402A - 402A
[30] Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAs
Yang, Fei
Xu, Shuqian
Huang, Chao
Shao, Zhiqiang
Hu, Yuefen
Yang, Yang
Lai, Yongrong
Ke, Qing
Liang, Dan
Wu, Yuxuan
GENES & DISEASES, 2024, 11 (01) : 15 - 18

← 1 2 3 4 5 →